Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

615 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis.
Stumme F, Steffens N, Steglich B, Mathies F, Nawrocki M, Sabihi M, Soukou-Wargalla S, Göke E, Kempski J, Fründt T, Weidemann S, Schramm C, Gagliani N, Huber S, Bedke T. Stumme F, et al. Among authors: schramm c. Front Immunol. 2024 Mar 6;15:1307297. doi: 10.3389/fimmu.2024.1307297. eCollection 2024. Front Immunol. 2024. PMID: 38510236 Free PMC article.
Colitis Promotes a Pathological Condition of the Liver in the Absence of Foxp3+ Regulatory T Cells.
Mathies F, Steffens N, Kleinschmidt D, Stuhlmann F, Huber FJ, Roy U, Meyer T, Luetgehetmann M, von Petersdorff M, Seiz O, Herkel J, Schramm C, Flavell RA, Gagliani N, Krebs C, Panzer U, Abdullah Z, Strowig T, Bedke T, Huber S. Mathies F, et al. Among authors: schramm c. J Immunol. 2018 Dec 15;201(12):3558-3568. doi: 10.4049/jimmunol.1800711. Epub 2018 Nov 16. J Immunol. 2018. PMID: 30446566
Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G, Neumann K, Berkhout LK, Weidemann S, Langeneckert AE, Schwinge D, Poch T, Huber S, Schiller B, Hess LU, Ziegler AE, Oldhafer KJ, Barikbin R, Schramm C, Altfeld M, Tiegs G. Ravichandran G, et al. Among authors: schramm c. J Hepatol. 2019 Oct;71(4):773-782. doi: 10.1016/j.jhep.2019.05.023. Epub 2019 Jun 5. J Hepatol. 2019. PMID: 31173810
Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis.
Poch T, Krause J, Casar C, Liwinski T, Glau L, Kaufmann M, Ahrenstorf AE, Hess LU, Ziegler AE, Martrus G, Lunemann S, Sebode M, Li J, Schwinge D, Krebs CF, Franke A, Friese MA, Oldhafer KJ, Fischer L, Altfeld M, Lohse AW, Huber S, Tolosa E, Gagliani N, Schramm C. Poch T, et al. Among authors: schramm c. J Hepatol. 2021 Aug;75(2):414-423. doi: 10.1016/j.jhep.2021.03.016. Epub 2021 Mar 24. J Hepatol. 2021. PMID: 33774059 Free PMC article.
A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis.
Wittek A, Steglich B, Casar C, Seiz O, Huber P, Ehlken H, Reher D, Wende S, Bedke T, Kempski J, Böttcher M, Bang C, Thingholm L, Krech T, Lohse AW, Sauter G, Rösch T, Franke A, Schramm C, Gagliani N, Pelczar P, Huber S. Wittek A, et al. Among authors: schramm c. Inflamm Bowel Dis. 2023 Aug 4:izad137. doi: 10.1093/ibd/izad137. Online ahead of print. Inflamm Bowel Dis. 2023. PMID: 37540889
TGF-beta and CD4+CD25+ regulatory T cells.
Huber S, Schramm C. Huber S, et al. Among authors: schramm c. Front Biosci. 2006 Jan 1;11:1014-23. doi: 10.2741/1859. Front Biosci. 2006. PMID: 16146793 Review.
Criteria Used in Clinical Practice to Guide Immunosuppressive Treatment in Patients with Primary Sclerosing Cholangitis.
Schulze K, Weismüller TJ, Bubenheim M, Huebener P, Zenouzi R, Lenzen H, Rupp C, Gotthardt D, de Leuw P, Teufel A, Zimmer V, Reiter FP, Rust C, Tharun L, Quaas A, Weidemann SA, Lammert F, Sarrazin C, Manns MP, Lohse AW, Schramm C; German PSC Study Group. Schulze K, et al. Among authors: schramm c. PLoS One. 2015 Oct 21;10(10):e0140525. doi: 10.1371/journal.pone.0140525. eCollection 2015. PLoS One. 2015. PMID: 26489083 Free PMC article.
615 results